The Relationship Between Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Treatment Response in Patients With Glomerulonephritis: A Single-Center Experience.

Cureus · 2023 · PMC10662779 · PMID 38021795

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

close to significancep = 0.057so close (0.05 < p ≤ 0.1)

Although there was no statistically significant difference between the suPAR levels in terms of the response to treatment (among 54 patients receiving immunosuppressive treatment), it was found close to significance since p = 0.057 (p > 0.05).

also in 572 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.